Thierry Piéton will be responsible for leading the Medtronic global finance organization and key supporting functions, including Treasury, Controller, Tax, Internal Audit, Investor Relations, Corporate Strategy, and Business Development.

In his new role, Dr. Mason will collaborate with the WorldQuant Foundry ecosystem of entrepreneurs and data scientists in an effort to identify and develop transformative opportunities in the healthcare sector.

“The expertise Chris Freeman brings in leading large-scale commercialization strategies is unparalleled,” said Dr Marcel Gehrung, Cyted Health’s CEO and Co-Founder. “Cyted Health’s transformative technology is already modernising diagnostic pathways across the UK. Chris’ insights will be instrumental as we pursue significant opportunities ahead of us in the US and globally.”

Kevin Hykes is an accomplished medical device industry executive with 30 years’ experience commercializing novel therapies on a global basis. Kevin is currently the President and CEO of Augmedics, a pioneer in augmented reality surgical navigation. Prior to joining Augmedics, Kevin was President and CEO of Bardy Diagnostics, which was acquired by Hillrom in August of 2021.

Alan Raffauf comes to Widex from Oticon Medical, where since 2009 he served as Vice President of Marketing with responsibility for the go-to-market readiness and lifecycle management of bone-anchored hearing products and cochlear implants for the United States and Canada.

Mathias Romacker is a distinguished executive. He joins Kymanox to support life science product development and commercialization.